Abpro Bio Co., Ltd. (KOSDAQ:195990)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,400.00
0.00 (0.00%)
At close: Feb 19, 2026

Abpro Bio Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
5,01015,49518,85616,95153,96126,840
Short-Term Investments
1,1826,119944.31796.04430.25-
Trading Asset Securities
-43.4368.364,087-4,045
Cash & Short-Term Investments
6,19221,65719,86921,83454,39130,885
Cash Growth
-80.22%9.00%-9.00%-59.86%76.11%106.35%
Accounts Receivable
5,50510,0963,9943,2262,7814,085
Other Receivables
633.56880.071,0393251,412625.75
Receivables
8,69812,2617,8684,4514,1934,837
Inventory
11,83113,53416,43218,61015,18912,664
Prepaid Expenses
-598.4837.4340.62520.3564.26
Other Current Assets
1,182930.47598.36857.227,6108,858
Total Current Assets
27,90348,98144,80445,79381,90357,808
Property, Plant & Equipment
22,49521,57422,57923,09924,17039,552
Long-Term Investments
4,92643,49556,41379,77257,30861,656
Goodwill
13,49613,4968,004---
Other Intangible Assets
3,2333,3383,4822,3883,621500.14
Long-Term Accounts Receivable
37.43112.81252---
Long-Term Deferred Tax Assets
363.55575.98125.75---
Other Long-Term Assets
8,7709,3316,4505,563848.946,256
Total Assets
81,643141,263142,110156,646167,884166,028
Accounts Payable
2,1436,8552,1271,5592,9112,227
Accrued Expenses
790.07652.56755.34733.9478.751,682
Short-Term Debt
2,5858,7359,24910,19621,0132,495
Current Portion of Long-Term Debt
991.35971.3333.16---
Current Portion of Leases
343.9383.92367.48303.02214.43195.64
Current Income Taxes Payable
--7.35--3.21
Other Current Liabilities
2,2283,4185,0853,2175,1438,229
Total Current Liabilities
9,08121,01517,92516,00929,76014,831
Long-Term Debt
11,36711,5061,294--8,463
Long-Term Leases
343.64456.43550.76441.24582.9241.35
Long-Term Deferred Tax Liabilities
-213.32----
Other Long-Term Liabilities
63.159.75-0004,294
Total Liabilities
20,85633,25119,76916,45030,34327,830
Common Stock
142,345142,345142,345136,845130,102125,735
Additional Paid-In Capital
89,78689,78689,11687,28885,63583,596
Retained Earnings
-176,403-128,564-112,935-87,193-79,070-68,918
Treasury Stock
-2.9-2.9-2.9-2.9-2.9-2.9
Comprehensive Income & Other
5,0624,4483,8173,259876.8-1,310
Total Common Equity
60,787108,012122,340140,196137,541139,100
Minority Interest
------902.41
Shareholders' Equity
60,787108,012122,340140,196137,541138,198
Total Liabilities & Equity
81,643141,263142,110156,646167,884166,028
Total Debt
15,63122,05311,79410,94021,81111,395
Net Cash (Debt)
-9,439-395.598,07510,89332,58119,491
Net Cash Growth
---25.88%-66.56%67.16%-
Net Cash Per Share
-331.52-13.57290.17406.051208.38909.55
Filing Date Shares Outstanding
28.4728.4728.4727.3726.0225.15
Total Common Shares Outstanding
28.4728.4728.4727.3726.0225.15
Working Capital
18,82127,96626,87929,78352,14342,976
Book Value Per Share
2135.233794.054297.355122.465285.925531.54
Tangible Book Value
44,05991,178110,854137,808133,920138,600
Tangible Book Value Per Share
1547.613202.743893.895035.225146.755511.65
Land
11,74011,74010,00010,00010,00011,475
Buildings
11,4159,87318,48018,49418,60726,565
Machinery
5,3725,4996,9967,3527,21817,595
Construction In Progress
-14.55500-145.23148
Source: S&P Global Market Intelligence. Standard template. Financial Sources.